News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
Views & Analysis A true story: Living with AIDS A 50-year-old man relates his personal experience of living with the condition.
News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
![iStock-497484764 [Converted]](https://pharmaphorum.com/wp-content/uploads/2016/11/world-aids-day-image.jpg)
